|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Selling, general and administrative | |||||
| Marketing | |||||
| Restructuring | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest and other income (expense), net | |||||
| Loss before provision for income taxes | |||||
| Effective tax rate | |||||
| Net loss | |||||
| Net loss per share attributable to common stockholders: | |||||
| Basic (in USD per share) | |||||
| Diluted (in USD per share) | |||||
| Weighted-average shares used in computing net loss per share attributable to common stockholders: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Other comprehensive loss | |||||
| Unrealized gain on short-term investments, net of taxes | |||||
| Comprehensive loss |
Loading...